Autoimmune hemolytic anemia historical perspective

Revision as of 19:23, 29 March 2018 by Shyam Patel (talk | contribs)
Jump to navigation Jump to search

Autoimmune hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune hemolytic anemia historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune hemolytic anemia historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune hemolytic anemia historical perspective

CDC on Autoimmune hemolytic anemia historical perspective

Autoimmune hemolytic anemia historical perspective in the news

Blogs on Autoimmune hemolytic anemia historical perspective

Directions to Hospitals Treating Autoimmune hemolytic anemia

Risk calculators and risk factors for Autoimmune hemolytic anemia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S; Shyam Patel [2]

Overview

Historical Perspective

  • In 1958, Leslie Zieve conducted a retrospective study on patients with alcoholic liver disease who had hemolytic anemia.[1]
  • In 1968, Balcerzak confirmed the phenomenon of hemolytic anemia in conjunction with cholestatic jaundice and hypercholesterolemia.[1] This condition was known as Zieve syndrome, named after Leslie Zieve.
  • In 1970, Zuelzer and colleagues from Wayne State School of Medicine in Detroit described the nature and proposed etiologies of autoimmune hemolytic anemia [2] They noted that autoantibodies could be produced by transient viral infections, such as CMV infection.[2] It was noted that there was a close correlation between the onset of infection and presence of hemolysis. Zuelzer and colleagues proposed in their manuscript that the etiology for autoimmune hemolytic anemia was an immunologic handicap predisposing to occult viral infections.
  • In 1973, Playfair and Marshall-Clarke developed a murine model of autoimmune hemolytic anemia. In this murine model, the mice developed autoantibodies against their own red blood cells upon injection of rat red blood cells. The rat red blood cells triggered antibody production, since the rat antigens were foreign, but the antibodies also reacted against self antigens (murine antigens) also [3] Clinically, the mice developed anemia, elevated reticulocyte count, and positive direct antiglobulin test (Coomb's test). The mice had decreased survival.[3]

References

  1. 1.0 1.1 Liu MX, Wen XY, Leung YK, Zheng YJ, Jin MS, Jin QL; et al. (2017). "Hemolytic anemia in alcoholic liver disease: Zieve syndrome: A case report and literature review". Medicine (Baltimore). 96 (47): e8742. doi:10.1097/MD.0000000000008742. PMC 5708965. PMID 29381966.
  2. 2.0 2.1 Zuelzer WW, Mastrangelo R, Stulberg CS, Poulik MD, Page RH, Thompson RI (1970). "Autoimmune hemolytic anemia. Natural history and viral-immunologic interactions in childhood". Am J Med. 49 (1): 80–93. PMID 4194012.
  3. 3.0 3.1 Mqadmi A, Zheng X, Yazdanbakhsh K (2005). "CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia". Blood. 105 (9): 3746–8. doi:10.1182/blood-2004-12-4692. PMC 1895013. PMID 15637139.

Template:Hematology


Template:WikiDoc Sources